The best time to take rasagiline (Azila) and factors affecting its efficacy

Rasagiline (Rasagiline) is a selective monoamine oxidaseB (MAO-B) inhibitor. It is mainly used for patients with early-stage Parkinson's disease or intermediate and advanced patients treated with levodopa. It inhibits dopamine metabolism and increases dopamine concentration in the brain, thereby improving motor symptoms such as tremor, stiffness and bradykinesia. The correct taking time can ensure that the blood concentration of the drug is stable, so as to achieve the best effect.

Rasagiline is usually taken as an oral tablet, taken once daily. It is recommended to take it at the same time every morning, with or without food. Taking the medication in the morning allows the medication to have a stable effect during the day when symptoms are more pronounced, while avoiding possible sleep disruption at night. Taking medication at a fixed time can also help patients form a regular medication habit and reduce the risk of missing or repeated doses.

The efficacy of rasagiline may be affected by many factors, including: the patient's liver function status (the drug is mainly metabolized by the liver), interactions with other drugs (such as containing SSRIs and certain antidepressant drugs that may increase the risk of adverse reactions), the patient's age and disease duration, and medication compliance. Diet has little impact on the efficacy, but patients should avoid the risk of adverse reactions caused by concurrent use of high-tyrosine or high-tyramine foods.

To ensure the efficacy of rasagiline, patients should strictly follow the prescribed medication schedule and regularly evaluate the efficacy and safety under the guidance of a doctor. If adverse reactions such as dizziness, hypotension or insomnia occur, the doctor should be reported promptly and the dosage should be adjusted. Taking medication at a fixed time, paying attention to drug interactions and regular monitoring are the keys to ensuring the safety of rasagiline and effectively controlling the symptoms of Parkinson's disease.

Reference link:https://www.drugs.com